STSS (Sharps Technology, Inc.) Market Value to Book Value Ratio

Sharps Technology (STSS) - corporate logo

The price trend shown below on GURU.Markets for medtech manufacturer Sharps Technology, Inc. (STSS), whose metric is 0.40, demonstrates a period of management adaptation to scaling production output. Growth is supported by the implementation of innovative safety syringes and the expansion of partnerships with clinics. However, geopolitical tensions and trade disputes are driving up raw material costs, creating risks for global logistics and shipments.

STSS - sharpstechnology.com Market-to-Book Ratio over the range 04/28/2023 - 05/28/2026
Manufactured products of Sharps Technology, Inc.

For long-term risk analysis, it is essential to understand how the market values the issuer's net assets relative to its market value. The current ratio of market capitalization to book value demonstrates a premium or discount to the balance sheet, where low values limit the downside but may indicate operating losses. In the case of Sharps Technology, Inc. (STSS), this indicator reflects the balance between stringent FDA regulation and the high value of intellectual property for safety syringes.

Direct competitors

Intuitive Surgical - Market Value to Book Value Ratio|DHR (danaher.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|INFU: Market Value to Book Value Ratio|Market Capitalization to Book Value Utah Med (UTMD)|Market Cap to Net Assets Ratio KORU Medical Systems|Market Cap to Book Value Multiple NYXH (nyxoah.com)|Market Value to Book Value Ratio Microbot Medical|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value